<table border="1" frame="border" id="table_6" rules="all" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6: Clinically Significant Drug Interactions with Paricalcitol</caption>
<colgroup>
<col width="18*"></col>
<col width="81*"></col>
</colgroup>
<tbody>
<tr>
<td colspan="2">
<content stylecode="bold">CYP3A Inhibitors</content>
</td>
</tr>
<tr>
<td>
<content stylecode="italics">Clinical Impact</content>
</td>
<td>Paricalcitol is partially metabolized by CYP3A. Hence, exposure of paricalcitol will increase upon coadministration with strong CYP3A inhibitors such as but not limited to: boceprevir, clarithromycin, conivaptan, grapefruit juice, indinavir, itraconazole, ketoconazole, lopinavir/ritonavir, mibefradil, nefazodone, nelfinavir, posaconazole, ritonavir, saquinavir, telaprevir, telithromycin, voriconazole.</td>
</tr>
<tr>
<td>
<content stylecode="italics">Intervention</content>
</td>
<td>Dose adjustment of paricalcitol capsules may be necessary. Monitor closely for iPTH and serum calcium concentrations, if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor.</td>
</tr>
<tr>
<td colspan="2">
<content stylecode="bold">Cholestyramine</content>
</td>
</tr>
<tr>
<td>
<content stylecode="italics">Clinical Impact</content>
</td>
<td>Drugs that impair intestinal absorption of fat-soluble vitamins, such as cholestyramine, may interfere with the absorption of paricalcitol.</td>
</tr>
<tr>
<td>
<content stylecode="italics">Intervention</content>
</td>
<td>Recommend to take paricalcitol capsules at least 1 hour <content stylecode="underline">before</content> or 4 to 6 hours <content stylecode="underline">after</content> taking cholestyramine (or at as great an interval as possible) to avoid impeding absorption of paricalcitol.</td>
</tr>
<tr>
<td colspan="2">
<content stylecode="bold">Mineral Oil</content>
</td>
</tr>
<tr>
<td>
<content stylecode="italics">Clinical Impact</content>
</td>
<td>Mineral oil or other substances that may affect absorption of fat may influence the absorption of paricalcitol.</td>
</tr>
<tr>
<td>
<content stylecode="italics">Intervention</content>
</td>
<td>Recommend to take paricalcitol capsules at least 1 hour <content stylecode="underline">before</content> or 4 to 6 hours <content stylecode="underline">after</content> taking mineral oil (or at as great an interval as possible) to avoid affecting absorption of paricalcitol. </td>
</tr>
</tbody>
</table>